This is concordant with the clonal sweeping model proposed by Makishima et al. regarding the disease progression of MDS from LR-MDS to HR-MDS, with RUNX1 mutation being one of the “type 2 mutations” [71]. This evidence concerns the gene RUNX1 and myelodysplastic syndrome.